DiscussWorldIssues - Socio-Economic Religion and Political Uncensored Debate - View Single Post

**addisonnicogel** · 10-31-2012, 01:22 PM

OK, some context. Firstly, there is nothing to stop the young woman concerned directly approaching the pharmaceutical company privately ie: outwith the NHS and taking them up on their free trial. The NHS of course will then not be obliged to continue to treat her with that drug once the free offer runs out. The pharmaceutical company however seems to be playing a rather cynical game of 'sprat to catch a mackerel'; rather like the narcotics dealer on the street, they are in effect saying "you can have the first dose or three for free, but then it's gonna cost you". Then there is the point of taxpayers' money being involved whenever the NHS comes into play: NHS managers, particularly in this age of austerity and budget cuts, just like medical insurance companies on your side of the Pond, constantly have to ask themselves "can we really justify to our paymasters spending £182000pa per patient on a drug like this" when it's taxpayers' money being spent.

10-31-2012, 01:22 PM	#15
addisonnicogel Join Date Oct 2005 Posts 516 Senior Member	OK, some context. Firstly, there is nothing to stop the young woman concerned directly approaching the pharmaceutical company privately ie: outwith the NHS and taking them up on their free trial. The NHS of course will then not be obliged to continue to treat her with that drug once the free offer runs out. The pharmaceutical company however seems to be playing a rather cynical game of 'sprat to catch a mackerel'; rather like the narcotics dealer on the street, they are in effect saying "you can have the first dose or three for free, but then it's gonna cost you". Then there is the point of taxpayers' money being involved whenever the NHS comes into play: NHS managers, particularly in this age of austerity and budget cuts, just like medical insurance companies on your side of the Pond, constantly have to ask themselves "can we really justify to our paymasters spending £182000pa per patient on a drug like this" when it's taxpayers' money being spent.
	Quote